You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
The global Glucagon Like Peptide-1 (GLP-1) Agonists market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Glucagon Like Peptide-1 (GLP-1) Agonists by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Pharmacy
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2.2 Downstream
Table Application Segment of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Glucagon Like Peptide-1 (GLP-1) Agonists Market by Type
3.1 By Type
3.1.1 Exenatied
Table Major Company List of Exenatied
3.1.2 Liraglutide
Table Major Company List of Liraglutide
3.1.3 Lixisenatide
Table Major Company List of Lixisenatide
3.1.4 Albiglutide
Table Major Company List of Albiglutide
3.1.5 Dulaglutide
Table Major Company List of Dulaglutide
3.2 Market Size
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2016-2020, by Type, in USD Million
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2016-2020, by Type, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2016-2020, by Type, in Volume
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2021-2026, by Type, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Novo Nordisk (Company Profile, Sales Data etc.)
4.1.1 Novo Nordisk Profile
Table Novo Nordisk Overview List
4.1.2 Novo Nordisk Products & Services
4.1.3 Novo Nordisk Business Operation Conditions
Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 AstraZeneca (Company Profile, Sales Data etc.)
4.2.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.2.2 AstraZeneca Products & Services
4.2.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Eli Lily (Company Profile, Sales Data etc.)
4.3.1 Eli Lily Profile
Table Eli Lily Overview List
4.3.2 Eli Lily Products & Services
4.3.3 Eli Lily Business Operation Conditions
Table Business Operation of Eli Lily (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 GSK (Company Profile, Sales Data etc.)
4.4.1 GSK Profile
Table GSK Overview List
4.4.2 GSK Products & Services
4.4.3 GSK Business Operation Conditions
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Sanofi (Company Profile, Sales Data etc.)
4.5.1 Sanofi Profile
Table Sanofi Overview List
4.5.2 Sanofi Products & Services
4.5.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
4.6.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
4.6.2 Bristol-Myers Squibb Products & Services
4.6.3 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Amylin (Company Profile, Sales Data etc.)
4.7.1 Amylin Profile
Table Amylin Overview List
4.7.2 Amylin Products & Services
4.7.3 Amylin Business Operation Conditions
Table Business Operation of Amylin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue 2016-2020, by Company, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Share in 2020, by Company, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume 2016-2020, by Company, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration, in 2020
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Market Concentration, in 2020
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists MMarket Concentration, in 2020
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration, in 2020
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Hospital, 2016-2020, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Hospital, 2016-2020, in Volume
6.1.2 Demand in Pharmacy
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Pharmacy, 2016-2020, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Pharmacy, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Others, 2016-2020, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Glucagon Like Peptide-1 (GLP-1) Agonists Demand Forecast 2021-2026, by Application, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2021-2026, by Application, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Share in 2026, by Application, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Demand Forecast 2021-2026, by Application, in Volume
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2021-2026, by Application, in Volume
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Glucagon Like Peptide-1 (GLP-1) Agonists Production 2016-2020, by Region, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2016-2020, by Region, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share 2016-2020, by Region, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2016-2020, by Region, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2016-2020, in USD Million
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2016-2020, by Country, in USD Million
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2016-2020, in USD Million
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2016-2020, by Country, in USD Million
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2016-2020, in USD Million
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2016-2020, by Country, in USD Million
Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2021-2026, by Region, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Feb, 2021
  • NO OF PAGES: 44236